CA2004646C - Protease, transcriptase inverse et endonucleases de retrovirus, et methode de production de ces enzymes - Google Patents

Protease, transcriptase inverse et endonucleases de retrovirus, et methode de production de ces enzymes

Info

Publication number
CA2004646C
CA2004646C CA002004646A CA2004646A CA2004646C CA 2004646 C CA2004646 C CA 2004646C CA 002004646 A CA002004646 A CA 002004646A CA 2004646 A CA2004646 A CA 2004646A CA 2004646 C CA2004646 C CA 2004646C
Authority
CA
Canada
Prior art keywords
retroviral
protease
gene
reverse transcriptase
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002004646A
Other languages
English (en)
Other versions
CA2004646A1 (fr
Inventor
Atsusi Saito
Hideo Shinagawa
Atsuo Nakata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1088411A external-priority patent/JP2852431B2/ja
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Publication of CA2004646A1 publication Critical patent/CA2004646A1/fr
Application granted granted Critical
Publication of CA2004646C publication Critical patent/CA2004646C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002004646A 1988-12-07 1989-12-05 Protease, transcriptase inverse et endonucleases de retrovirus, et methode de production de ces enzymes Expired - Fee Related CA2004646C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP30942788 1988-12-07
JP309,427/1988 1988-12-07
JP88,411/1989 1989-04-06
JP1088411A JP2852431B2 (ja) 1988-12-07 1989-04-06 レトロウイルスのプロテアーゼ、逆転写酵素及びエンドヌクレアーゼ、並びにこれ等の酵素の製法

Publications (2)

Publication Number Publication Date
CA2004646A1 CA2004646A1 (fr) 1990-06-07
CA2004646C true CA2004646C (fr) 1999-10-05

Family

ID=26429797

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002004646A Expired - Fee Related CA2004646C (fr) 1988-12-07 1989-12-05 Protease, transcriptase inverse et endonucleases de retrovirus, et methode de production de ces enzymes

Country Status (9)

Country Link
EP (1) EP0372904B1 (fr)
AT (1) ATE112318T1 (fr)
AU (1) AU643942B2 (fr)
CA (1) CA2004646C (fr)
DE (1) DE68918563T2 (fr)
DK (1) DK612889A (fr)
HU (1) HU209835B (fr)
MY (1) MY104975A (fr)
NZ (1) NZ231593A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059541C (fr) * 1990-05-28 1996-06-04 Atsusi Saito Methode d'obtention d'un plasmide qui a la capacite d'exprimer un gene retroviral et aussi la capacite de traitement ap es la traduction, et plasmide resultant ainsi que ses produits exprimes
WO1992011028A1 (fr) * 1990-12-19 1992-07-09 Epitope, Inc. Vaccin a transcriptase inverse contre le vih
EP0555797A1 (fr) * 1992-02-10 1993-08-18 Becton, Dickinson and Company Solution tampon universelle pour endonucléases de réstriction
EP0805873B1 (fr) * 1995-01-27 1999-09-01 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Procedes de detection sensible de transcriptase inverse
HUP9900388A3 (en) * 1996-01-29 2005-03-29 Virologic Inc South San Franci Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007296A1 (fr) * 1986-05-20 1987-12-03 The Trustees Of Columbia University In The City Of Expression de la transcriptase inverse du virus lymphotropique des lymphocytes t humains (htlv-iii), et utilisations

Also Published As

Publication number Publication date
MY104975A (en) 1994-07-30
AU4590889A (en) 1990-08-02
DE68918563D1 (de) 1994-11-03
HUT54412A (en) 1991-02-28
DK612889A (da) 1990-06-08
DK612889D0 (da) 1989-12-05
EP0372904B1 (fr) 1994-09-28
EP0372904A3 (fr) 1991-09-25
NZ231593A (en) 1992-07-28
AU643942B2 (en) 1993-12-02
ATE112318T1 (de) 1994-10-15
CA2004646A1 (fr) 1990-06-07
DE68918563T2 (de) 1995-02-23
HU896176D0 (en) 1990-02-28
HU209835B (en) 1994-11-28
EP0372904A2 (fr) 1990-06-13

Similar Documents

Publication Publication Date Title
CA2059541C (fr) Methode d'obtention d'un plasmide qui a la capacite d'exprimer un gene retroviral et aussi la capacite de traitement ap es la traduction, et plasmide resultant ainsi que ses produits exprimes
Larder et al. AIDS virus reverse transcriptase defined by high level expression in Escherichia coli.
Tritch et al. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein
JPS61173782A (ja) リンパ節疾患症候群および／または後天性免疫不全症候群に関連する組換えウイルスタンパク質
JPS62217161A (ja) ウイルス検出用キツト
JP2002159294A (ja) リンパ節障害関連ウイルス（ｌａｖ）のウイルスｒｎａから得られるｄｎａ
Weiss et al. Recombinant HIV-1 nucleocapsid protein p15 produced as a fusion protein with glutathione S-transferase in Escherichia coli mediates dimerization and enhances reverse transcription of retroviral RNA
Le Grice et al. A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity
CA2004646C (fr) Protease, transcriptase inverse et endonucleases de retrovirus, et methode de production de ces enzymes
AU609725B2 (en) Recombinant HTLV-III proteins and uses thereof
Deibel JR et al. Denaturation/refolding of purified recombinant HIV reverse transcriptase yields monomeric enzyme with high enzymatic activity
Szilvay et al. Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities
Amacker et al. Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66-and 51-kilodalton subunits
Saitoh et al. Overproduction of human immunodeficiency virus type I reverse transcriptase in Escherichia coli and purification of the enzyme
WO1990000556A1 (fr) Gene de protease de vih synthetique et son procede d'expression
US5500355A (en) Protease, reverse transcriptase and endonuclease of HIV-1 and RSV method for producing these enzymes
Rumlová et al. Comparison of classical and affinity purification techniques of Mason-Pfizer monkey virus capsid protein: the alteration of the product by an affinity tag
Müller et al. Characterization of human T‐cell leukemia virus type I integrase expressed in Escherichia coli
US5202259A (en) Expression of human immunodeficiency virus (HIV) reverse transcriptase
JPH09173100A (ja) ホップ潜在ウイルスの遺伝子及び該ウイルスの検出方法
NZ238278A (en) A plasmid having both the expressing ability of a retroviral gene and processing ability after translation
WO1990006369A1 (fr) Utilisation d'un site de clivage de protease de vih pour exprimer des proteines matures
JPS626679A (ja) ヒトリゾチ−ムの微生物学的製造法
EP0343132A2 (fr) Procédés et méthodes de production d'antigènes HIV
KR0166344B1 (ko) 사람 면역결핍 바이러스 타입 1의 항원단백질 p24를 제조하는 방법

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed